7AW5
Crystal structure of OXA-48 beta-lactamase in the complex with the inhibitor ID3
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID29 |
Synchrotron site | ESRF |
Beamline | ID29 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-02-18 |
Detector | DECTRIS PILATUS3 S 6M |
Wavelength(s) | 1.072 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 72.470, 73.680, 124.790 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 51.667 - 1.650 |
R-factor | 0.177 |
Rwork | 0.176 |
R-free | 0.20720 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3hbr |
RMSD bond length | 0.009 |
RMSD bond angle | 1.156 |
Data reduction software | MOSFLM |
Data scaling software | SCALEPACK |
Phasing software | AMoRE |
Refinement software | PHENIX (1.8.4_1496) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 51.670 | 1.680 |
High resolution limit [Å] | 1.650 | 1.650 |
Number of reflections | 80899 | 3950 |
<I/σ(I)> | 11.5 | |
Completeness [%] | 99.8 | |
Redundancy | 2.5 | |
CC(1/2) | 0.995 | 0.916 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1 M Hepes, pH 7.5, 12% PEG8000, 8% 1-butanol, OXA-48 8.0-8.5 mg/ml, inhibitor/protein ratio 6.5:1 |